Sign in

CIK 0001826457

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Monte Rosa Therapeutics, Inc.

Sign in to watch
Ticker
GLUE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-949-2643
Business address
321 HARRISON AVENUE, SUITE 900, BOSTON, MA, 02118
Former names
Monte Rosa Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$137
in 1 filing

Net −$137. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Bowen Matthew −$137 Principal Accounting Officer sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2026-06-11 Siu Christine Director Grant or award · Stock Option (Right to Buy) +25,800 25,800
2025-06-13 Siu Christine Director Grant or award · Stock Option (Right to Buy) +30,700 30,700
2024-06-12 Siu Christine Director Grant or award · Stock Option (Right to Buy) +22,100 22,100
2023-06-14 Siu Christine Director Grant or award · Stock Option (Right to Buy) +20,500 20,500
2022-06-15 Siu Christine Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2021-06-23 Siu Christine Director Grant or award · Stock Option (Right to Buy) +47,132 47,132
2021-04-12 Siu Christine Director Grant or award · Stock Option (Right to Buy) +7,081 7,081

Page 1 of 1 · 7 trades